HIMS & HERS HEALTH INC (HIMS)

US4330001060 - Common Stock

34.23  +2.63 (+8.32%)

After market: 34.01 -0.22 (-0.64%)

News Image
3 days ago - Investor's Business Daily

The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market

An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in obesity.

News Image
10 days ago - Chartmill

Exploring growth characteristics of HIMS & HERS HEALTH INC (NYSE:HIMS).

Should you consider HIMS & HERS HEALTH INC (NYSE:HIMS) for growth investing?

News Image
11 days ago - The Motley Fool

Why Hims & Hers Stock Jumped on Massive FDA News

Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model.

News Image
12 days ago - Bloomberg

Hims & Hers Shares Jump as Trump’s FDA Pick Seen as Major Ally

Hims & Hers Health Inc. shares surged as much as 18% and are on track to close at fresh record after Hunterbrook Media said the company is poised to be a major beneficiary of President-elect Donald Trump’s nomination of Marty Makary to lead the Food and Drug Administration.

News Image
15 days ago - The Motley Fool

Hims & Hers New Growth Category Is a Huge Surprise

Is the food business the right business for Hims & Hers to be in?

News Image
17 days ago - Investor's Business Daily

Guardant Health Stock Sees RS Rating Jump To 83

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83.

News Image
21 days ago - The Motley Fool

Hims & Hers Stock Is Down 30% This Week: Here's What Happened

Hims & Hers has given back recent gains, but don't overlook the company's massive growth.

News Image
23 days ago - Bloomberg

Hims Drops Most Ever as Amazon Enters Hair-Loss Drug Market

Hims & Hers Health Inc. shares dropped the most in their five-year history after Amazon.com Inc. said it would start marketing drugs to fight hair loss, an important component of the telehealth company’s business.